Our three Sunday stories include a healthcare innovator with heart, a crypto exchange going corporate, and an aerospace legend ready for its second act.
Meta, Microsoft, Amazon, and Alphabet are spending billions. Analysts say one stands above the rest.
ZM’s pandemic hype is gone. Now, it's become a cash-rich hybrid-work staple — and a new kind of tech value play.
Sohn speakers named MGNI and BLND as two under-the-radar plays with comeback potential.
Progressive’s slump looks like a buying opportunity, not a breakdown. Here’s why analysts are staying long.
What’s Berkshire worth without Buffett? KBW’s downgrade raises a hard question.
Our three Sunday stories include the gas giant fueling AI’s next growth spurt, a data-center player thriving on its own, and a chatbot quietly taking over online shopping.
Municipal bonds are still lagging Treasuries — but their fundamentals say “not for long.”
AMZN’s robotic overhaul could slash fulfillment costs by 40% and redefine what efficiency means in retail.
APP’s move into e-commerce ads could be a game changer. Deutsche Bank says there’s more upside to come.
Colgate gets an Outperform from Evercore. When AI hype fades, toothpaste could keep portfolios minty fresh.
TD Cowen says Ally's shift toward prime borrowers and tighter underwriting has it back on track for growth.
$RY tops Canada’s Evident AI Index, suggesting even old-school lenders can be new-economy winners.
Our three Sunday stories include an unsung hero powering the digital future, a mining play shining in the commodity comeback, and a new wave of energy startups chasing lightning in a bottle.
ZION just saw a billion-dollar selloff. Baird says the fear was misplaced, and the rebound could follow.
RKLB dominates small-lift launches. Now its reusable rockets could power it toward $200, says Baird.
Citi sees upside in LOGI as workers and gamers alike refresh gear.
JPMorgan calls PTRN an “e-commerce accelerator” worth watching. AI-driven retail could be its edge... and its upside.
RBC calls SFM an appealing entry point. Sales growth and new products could drive fresh returns.
Our three Sunday stories include frozen assets ready to defrost, an AI titan that’s just getting warmed up, and a humble PC maker turning into a server king.
With margins holding up and international growth steady, Weatherford could be a value play worth another look.
DraftKings gets a fresh Buy from Berenberg. Analysts say the pullback may be your best entry in months.
CG Oncology's lead therapy could redefine bladder cancer care. Guggenheim’s Buy call points to a promising path to FDA approval.
Astera Labs open-standard tech could make it one of AI’s top hardware plays.
Klarna's IPO pop cooled off, but Wall Street’s heating up. UBS, Deutsche, and JPMorgan all see major upside ahead.
